According to the Complaint, iRhythm Technologies, Inc. is a digital healthcare company that seeks to "redefin[e] the way cardiac arrythmias are clinically diagnosed by combining [the Company's] wearable biosensing technology with cloud-based data analytics and deep-learning capabilities." iRhythm offers a portfolio of ambulatory cardiac monitoring services on its platform, called the Zio service.
We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.